Skip to main content
Signal8

SMITH SCOTT THOMAS

SEC insider (Form 3/4/5 filer). CIK 0001965550. EVP & Chief Financial Officer at Ascendis Pharma A/S (ASND). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 2, 2026. Located in HELLERUP.

Companies SMITH SCOTT THOMAS has filed insider reports for

  • Ascendis Pharma A/S (ASND): Officer, EVP & Chief Financial Officer
SMITH SCOTT THOMAS profile photo

SMITH SCOTT THOMAS

CIK: 0001965550

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Ascendis Pharma A/S logo
ASND

Ascendis Pharma A/S

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Ascendis Pharma A/S logo
    ASND

    Ascendis Pharma A/S

    Jun 2, 2026
    Purchase
    Direct
    100 shares at avg. $219.00$22K
  • Ascendis Pharma A/S logo
    ASND

    Ascendis Pharma A/S

    May 29, 2026
    Purchase
    Direct
    250 shares at avg. $223.32$56K

1-2 of 2